107 related articles for article (PubMed ID: 11421561)
1. Loss of heterogeneous ribonucleoprotein A(2)/B(1) expression in thyroid neoplasms.
Bidot P; Morgan M; Zhukov T; Tannenbaum M; Tockman MS
Endocr Pract; 2001; 7(3):157-61. PubMed ID: 11421561
[TBL] [Abstract][Full Text] [Related]
2. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
3. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
[TBL] [Abstract][Full Text] [Related]
4. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions.
Aiad HA; Bashandy MA; Abdou AG; Zahran AA
Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017
[TBL] [Abstract][Full Text] [Related]
5. Analysis of P161NK4A protein expression in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
Pol J Pathol; 2004; 55(4):143-8. PubMed ID: 15757201
[TBL] [Abstract][Full Text] [Related]
6. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
[TBL] [Abstract][Full Text] [Related]
7. NDRG1 protein overexpression in malignant thyroid neoplasms.
Gerhard R; Nonogaki S; Fregnani JH; Soares FA; Nagai MA
Clinics (Sao Paulo); 2010 Jun; 65(8):757-62. PubMed ID: 20835551
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma.
Kim JY; Cho H; Rhee BD; Kim HY
Acta Cytol; 2002; 46(4):679-83. PubMed ID: 12146030
[TBL] [Abstract][Full Text] [Related]
9. Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy.
Ippolito A; Vella V; La Rosa GL; Pellegriti G; Vigneri R; Belfiore A
Thyroid; 2001 Aug; 11(8):783-7. PubMed ID: 11525273
[TBL] [Abstract][Full Text] [Related]
10. [Expression of BRAF V600E mutation in different thyroid lesions].
Wang W; Li XH; Zhang YH; Li J; Chen J; Zhao P; Li QY; Xiang JJ; Li X; Xu RJ
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):354-7. PubMed ID: 21875464
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland.
Gaffney RL; Carney JA; Sebo TJ; Erickson LA; Volante M; Papotti M; Lloyd RV
Am J Surg Pathol; 2003 Apr; 27(4):494-8. PubMed ID: 12657934
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.
Lewy-Trenda I; Wierzchniewska-Ławska A
Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614
[TBL] [Abstract][Full Text] [Related]
13. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
14. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
[TBL] [Abstract][Full Text] [Related]
15. c-Met expression of thyroid tissue with special reference to papillary carcinoma.
Oyama T; Ichimura E; Sano T; Kashiwabara K; Fukuda T; Nakajima T
Pathol Int; 1998 Oct; 48(10):763-8. PubMed ID: 9788259
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of IGF-1 and IGF-1R in thyroid nodules.
Liu YJ; Qiang W; Shi J; Lv SQ; Ji MJ; Shi BY
Endocrine; 2013 Aug; 44(1):158-64. PubMed ID: 23288662
[TBL] [Abstract][Full Text] [Related]
17. Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Włoch J; Sałacińska-Los E; Kulig A; Jarzab B
Pol J Pathol; 2004; 55(4):149-53. PubMed ID: 15757202
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of S100C in thyroid lesions.
Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
[TBL] [Abstract][Full Text] [Related]
20. Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medullary thyroid carcinoma.
Liu YY; Morreau H; Kievit J; Romijn JA; Carrasco N; Smit JW
Eur J Endocrinol; 2008 Mar; 158(3):375-84. PubMed ID: 18299472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
